Jaguar Health (JAGX) FCF Margin (2015 - 2026)

Jaguar Health (JAGX) has 12 years of FCF Margin data on file, last reported at 43.56% in Q1 2026.

• FCF Margin for Q1 2026 came in at 43.56%, up 37391.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 25.46% (up 23121.0% YoY), and the FY2025 annual result was 206.12%, up 4539.0% from the prior year.
• FCF Margin rose to 43.56% in Q1 2026 per JAGX's latest filing, from 169.24% in the prior quarter.
• Over five years, FCF Margin peaked at 43.56% in Q1 2026 and troughed at 38475.0% in Q1 2022.
• A 5-year average of 4942.51% and a median of 299.74% in 2024 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2024: FCF Margin plunged 3793398 bps in 2022, then soared 2180026 bps in 2024.
• A 5-year view of FCF Margin shows it stood at 20071.88% in 2022, then surged by 98 bps to 323.96% in 2023, then jumped by 31 bps to 223.03% in 2024, then climbed by 24 bps to 169.24% in 2025, then jumped by 126 bps to 43.56% in 2026.
• Business Quant data shows JAGX's FCF Margin at 43.56% in Q1 2026, 169.24% in Q4 2025, and 152.09% in Q3 2025.